In this episode of “The Vitals,” Daniel J. Verina, DNP, RN, MSN, ACNP-BC, discusses clinical pearls in caring for patients receiving selinexor, an XPO-1 inhibitor.
For this episode of The Vitals, Oncology Nursing News® spoke with Daniel J. Verina, DNP, RN, MSN, ACNP-BC, of the Myeloma Team with Mount Sinai Medical Center, about optimal strategies for adverse event management for patients receiving selinexor (Xpovio). Verina recently presented on adverse event management for novel multiple myeloma therapies as part of the International Myeloma Society’s 6th Annual Nursing Symposium.
“I think one of the challenges is when a patient keeps relapsing and [you have] to come back to them and [say] you relapsed again, we have to change your treatment. That is a challenge—in all honesty.” Time stamp [TS] 9:04
“Patients tend to become dehydrated: You really want to make sure they have good oral fluid intake, [and] you want to be able to monitor diarrhea.” TS 12:52
“Low sodium was another big side effect that we saw in our patient population… I tell patients to eat salty snacks, which will help with their lack of eating and help with their weight.” TS 15:24
“One of my educational points with patients is that you want to be able to weigh yourself every day, at the same time, with the caregiver with them, to make sure that they're maintaining their same weight.” TS 19:01
“We always have a nutritionist jump in right away with our patients that start on selinexor to try to find the best nutritional support whether it's high calories and small packages be able to give those to patients up front so they can maintain their weight.” TS 19:14
The Vitals Podcast:
Oncology Nursing News® Online Articles
Oncology Nursing News® Publication Features